| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |